Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00056238 | Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy | PHASE2 | COMPLETED | 30 | — | — | Feb 1, 2003 | - | Jun 24, 2005 | 5 | United States |
| Name | Type | Description |
|---|---|---|
| NC-758 (Anti amyloidotic [Aß] agent) | DRUG | - |
Inclusion Criteria * Patients must be 55 years of age or older. * Males and females. Females must be of non-childbearing potential (i.e. surgically sterilized or at least one year post-menopausal). * Diagnosis of possible or probable CAA based on the Boston Criteria for Diagnosis of CAA-Related Hem...